PT Kalbe Farma Tbk. (IDX:KLBF)

Indonesia flag Indonesia · Delayed Price · Currency is IDR
1,515.00
-55.00 (-3.50%)
May 28, 2025, 4:14 PM WIB
-3.19%
Market Cap 69.06T
Revenue (ttm) 33.11T
Net Income (ttm) 3.36T
Shares Out 45.58B
EPS (ttm) 72.97
PE Ratio 20.76
Forward PE 19.32
Dividend 31.00 (2.05%)
Ex-Dividend Date Jun 4, 2025
Volume 162,559,500
Average Volume 51,459,220
Open 1,570.00
Previous Close 1,570.00
Day's Range 1,495.00 - 1,570.00
52-Week Range 985.00 - 1,795.00
Beta 0.04
RSI 60.40
Earnings Date Aug 1, 2025

About PT Kalbe Farma Tbk.

PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic divisions. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business; and E-health products. It operates Mitrasana Clinics, a health care service. In addition, the company pr... [Read more]

Sector Healthcare
Founded 1966
Employees 12,903
Stock Exchange Indonesia Stock Exchange
Ticker Symbol KLBF
Full Company Profile

Financial Performance

In 2024, PT Kalbe Farma Tbk.'s revenue was 32.63 trillion, an increase of 7.16% compared to the previous year's 30.45 trillion. Earnings were 3.24 trillion, an increase of 17.13%.

Financial Statements

News

There is no news available yet.